Related Experiment Video
Updated: Dec 24, 2025

Surgically Induced Cardiac Volume Overload by Aortic Regurgitation in Mouse
Published on: August 30, 2022
Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Severe Mitral Regurgitation
Shujuan Li1,2,3, Ngoc Uyen Nhi Nguyen3, Feng Xiao3
1Department of Pediatric Cardiology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China (S.L.).
Insights
Severe mitral regurgitation (MR) causes left ventricular (LV) dysfunction through maladaptive eccentric cardiomyocyte hypertrophy. Targeting mTOR signaling and cell polarity pathways may prevent this cardiac remodeling.
Area of Science:
- Cardiovascular Research
- Molecular Cardiology
- Cardiac Physiology
Background:
- Primary valvular heart disease, especially mitral regurgitation (MR), is a major cause of heart failure.
- Current treatments focus on valve repair/replacement, not preventing myocardial dysfunction.
- The mechanisms driving left ventricular (LV) dysfunction in severe MR remain unknown.
Purpose of the Study:
- To develop and characterize the first mouse model of severe MR.
- To elucidate the underlying mechanisms of LV dysfunction in this model.
- To identify potential therapeutic targets for MR-induced cardiac pathology.
Main Methods:
- Induction of severe MR in mice by surgically damaging the mitral valve.
- Serial echocardiography to assess LV morphology and function.
- Histological and molecular analyses of cardiac tissues, including RNA-sequencing.
Main Results:
- Induced MR led to progressive LV dilatation, eccentric hypertrophy, and severe systolic dysfunction over 15 weeks.
- Cardiomyocyte length increased, with sarcomere disarray and disruption.
- Activation of mTOR and calcineurin pathways was observed; mTOR inhibition preserved cardiac structure and function.
- Differential expression of Crb2 and increased polysome localization near intercalated disks were noted.
Conclusions:
- LV dysfunction in severe MR results from maladaptive eccentric cardiomyocyte hypertrophy.
- Cell polarity regulation and localized protein synthesis are key pathways in MR-induced cardiomyocyte growth.
- Targeting mTOR signaling offers a potential therapeutic strategy to prevent MR-induced cardiac remodeling.
Background:
Primary valvular heart disease is a prevalent cause of morbidity and mortality in both industrialized and developing countries. Although the primary consequence of valvular heart disease is myocardial dysfunction, treatment of valvular heart diseases centers around valve repair or replacement rather than prevention or reversal of myocardial dysfunction. This is particularly evident in primary mitral regurgitation (MR), which invariably results in eccentric hypertrophy and left ventricular (LV) failure in the absence of timely valve repair or replacement. The mechanism of LV dysfunction in primary severe MR is entirely unknown.
Methods:
Here, we developed the first mouse model of severe MR. Valvular damage was achieved by severing the mitral valve leaflets and chords with iridectomy scissors, and MR was confirmed by echocardiography. Serial echocardiography was performed to follow up LV morphology and systolic function. Analysis of cardiac tissues was subsequently performed to evaluate valve deformation, cardiomyocyte morphology, LV fibrosis, and cell death. Finally, dysregulated pathways were assessed by RNA-sequencing analysis and immunofluorescence.
Results:
In the ensuing 15 weeks after the induction of MR, gradual LV dilatation and dysfunction occurred, resulting in severe systolic dysfunction. Further analysis revealed that severe MR resulted in a marked increase in cardiac mass and increased cardiomyocyte length but not width, with electron microscopic evidence of sarcomere disarray and the development of sarcomere disruption. From a mechanistic standpoint, severe MR resulted in activation of multiple components of both the mammalian target of rapamycin and calcineurin pathways. Inhibition of mammalian target of rapamycin signaling preserved sarcomeric structure and prevented LV remodeling and systolic dysfunction. Immunohistochemical analysis uncovered a differential pattern of expression of the cell polarity regulator Crb2 (crumbs homolog 2) along the longitudinal axis of cardiomyocytes and close to the intercalated disks in the MR hearts. Electron microscopy images demonstrated a significant increase in polysome localization in close proximity to the intercalated disks and some areas along the longitudinal axis in the MR hearts.
Conclusions:
These results indicate that LV dysfunction in response to severe MR is a form of maladaptive eccentric cardiomyocyte hypertrophy and outline the link between cell polarity regulation and spatial localization protein synthesis as a pathway for directional cardiomyocyte growth.
Related Concept Videos
Mitral Regurgitation I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy

